about
Classification of current anticancer immunotherapiesTrial watch: Naked and vectored DNA-based anticancer vaccinesMulberry leaf polysaccharides modulate murine bone-marrow-derived dendritic cell maturationIdentification and validation of differentially expressed proteins in epithelial ovarian cancers using quantitative proteomics.Study on the mesothelin-specific cytotoxicity against epithelial ovarian cancer with full-length mesothelin cDNA-transduced dendritic cells.
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Dendritic cell-based immunotherapy in ovarian cancer.
@en
Dendritic cell-based immunotherapy in ovarian cancer.
@nl
type
label
Dendritic cell-based immunotherapy in ovarian cancer.
@en
Dendritic cell-based immunotherapy in ovarian cancer.
@nl
prefLabel
Dendritic cell-based immunotherapy in ovarian cancer.
@en
Dendritic cell-based immunotherapy in ovarian cancer.
@nl
P2860
P356
P1433
P1476
Dendritic cell-based immunotherapy in ovarian cancer.
@en
P2093
An Coosemans
Stefaan W Van Gool
P2860
P304
P356
10.4161/ONCI.27059
P577
2013-11-06T00:00:00Z